Moderna, Inc. (0QF.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 05:54PM CEST
| Previous Close | 122.00 |
| Open | 121.84 |
| Bid | 121.58 x 0 |
| Ask | 121.90 x 0 |
| Day's Range | 121.22 - 122.76 |
| 52 Week Range | 59.44 - 132.06 |
| Volume | |
| Avg. Volume | 789 |
| Market Cap | 46.809B |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
- Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
- Investor's Business Daily
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
© 2024 Yahoo. All rights reserved.